Mass. State Rep. Calls on University VP to Increase Transparency for Allston Multimodal Project
Harvard President Lawrence Bacow Made $1.1 Million in 2020, Financial Disclosures Show
Harvard Executive Vice President Katie Lapp To Step Down
81 Republican Lawmakers File Amicus Brief Supporting SFFA in Harvard Affirmative Action Lawsuit
Duke Senior’s Commencement Speech Appears to Plagiarize 2014 Address by Harvard Student
Last night Eugene Kinasewich '64 rejoined the Crimson hockey squad in its game against Northeastern. Early in the afternoon he had left New York after appealing the September decision of the Eastern College Athletic Conference which declared him ineligible to play ECAC hockey.
The ECAC handed down their new decision allowing the Harvard star to play at 2:30 yesterday afternoon. The telegram from George Shiebler, secretary of the eligibility committee of the ECAC, to Dean Watson reads: "The ECAC eligibility committee today voted to restore the eligibility of Eugene Kinasewich.
"On the basis of unusual circumstances of which personal financial hardship was the underlying factor, the ECAC committee on eligibility, under provision of Article VIII of the ECAC rules of eligibility, hereby restores the eligibility of Eugene Kinasewich of Harvard University for intercollegiate athletic competition."
The National Collegiate Athletic Association has not yet revealed its decision on the eligibility of the Crimson forward, although its meeting was held Dec. 4. The result is not expected to differ from that of the ECAC.
Dean Watson, who has followed the case very closely since Kinasewich was first declared ineligible in the fall of 1960, said he was extremely pleased with the ECAC decision. He expressed thanks to "all those people who firmly believed in the case, who fought for it and helped to make the final decision possible."
"A great deal of credit," he continued, "must also go to the ECAC eligibility committee. Upon close examination they recognized the worthiness of the case."
Want to keep up with breaking news? Subscribe to our email newsletter.